Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Optic Neuropathy - Overview
Optic Neuropathy - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Optic Neuropathy - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Optic Neuropathy - Companies Involved in Therapeutics Development
Allergan Ltd
Antoxis Ltd
Biozeus Pharmaceutical SA
Neurizon Pharma GBR
PharmatrophiX Inc
Quark Pharmaceuticals Inc
Regenera Pharma Ltd
Regeneron Pharmaceuticals Inc
Optic Neuropathy - Drug Profiles
aflibercept - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
brimonidine tartrate implant - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BZ-371 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CSIC-002 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Optic Neuropathy - Dormant Projects
Optic Neuropathy - Discontinued Products
Optic Neuropathy - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Optic Neuropathy, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Targets, H2 2020
Number of Products by Stage and Targets, H2 2020
Number of Products by Mechanism of Actions, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Optic Neuropathy, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Optic Neuropathy - Pipeline by Allergan Ltd, H2 2020
Optic Neuropathy - Pipeline by Antoxis Ltd, H2 2020
Optic Neuropathy - Pipeline by Biozeus Pharmaceutical SA, H2 2020
Optic Neuropathy - Pipeline by Neurizon Pharma GBR, H2 2020
Optic Neuropathy - Pipeline by PharmatrophiX Inc, H2 2020
Optic Neuropathy - Pipeline by Quark Pharmaceuticals Inc, H2 2020
Optic Neuropathy - Pipeline by Regenera Pharma Ltd, H2 2020
Optic Neuropathy - Pipeline by Regeneron Pharmaceuticals Inc, H2 2020
Optic Neuropathy - Dormant Projects, H2 2020
Optic Neuropathy - Discontinued Products, H2 2020